In solution-phase peptide synthesis campaigns, L-alanine methyl ester hydrochloride functions as a stable C-terminal protected alanine equivalent. The hydrochloride salt is charged to a glass-lined or stainless steel reactor, typically after vacuum drying at 40–45 °C under reduced pressure, because the material is hygroscopic and will absorb atmospheric moisture above 60 % relative humidity. Dichloromethane or tetrahydrofuran is added, and the slurry is cooled to 0–5 °C. A tertiary amine, commonly triethylamine or N-methylmorpholine, is introduced in staged portions. The neutralization of the hydrochloride salt is exothermic; the addition rate is set so that the batch temperature remains near 0–5 °C during the final stage. The liberated methyl ester remains in the organic phase, while the tertiary ammonium chloride precipitates or partitions into the aqueous phase if water is present. The free amine is not stored because it is prone to self-condensation and carbon dioxide uptake. It is coupled immediately with an N-protected amino acid, frequently Boc-L-alanine, Fmoc-L-alanine, or Cbz-L-alanine. Coupling reagents are selected from dicyclohexylcarbodiimide-hydroxybenzotriazole, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride plus hydroxybenzotriazole, or benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate. The activated ester is formed at 0–5 °C, then the pre-cooled free amine solution is added over 30–60 min. The reaction mixture is held for a period determined by thin-layer chromatography or HPLC. Aqueous workup uses sequential washes with 5 % w/w citric acid, 5 % w/w sodium bicarbonate, and 20 % w/w sodium chloride solution. The sodium bicarbonate wash pH is maintained between 7.5 and 8.5 so that the methyl ester is not saponified; at pH values above 9.0, base-catalyzed hydrolysis accelerates and the corresponding free acid contaminates the product. The organic layer is dried over anhydrous sodium sulfate, filtered, and concentrated in a rotary evaporator or wiped-film evaporator with a jacket temperature not exceeding 40 °C for Fmoc-protected dipeptide esters. The crude dipeptide methyl ester is purified by crystallisation or silica gel chromatography. Release testing for pharmaceutical intermediate use includes HPLC purity, chiral HPLC for enantiomeric excess, residual solvent analysis by headspace gas chromatography according to USP <467>, and water content by Karl Fischer titration according to USP <921>. Production documentation follows ICH Q7 for the manufacture of advanced intermediates. The principal processing failure observed in multi-kilogram batches is premature methyl ester hydrolysis during the bicarbonate wash when the pH probe calibration drifts; periodic verification with pH 7.00 and pH 10.00 buffer standards before each batch reduces this source of batch-to-batch variation.

Retaining the Methyl Ester During Acylation in a Water-Organic Biphasic Reactor

Production of N-acyl-L-alanine methyl ester from L-alanine methyl ester hydrochloride is carried out in a biphasic system containing water and a low-polarity solvent such as toluene, methyl tert-butyl ether, or ethyl acetate. The hydrochloride is dissolved in water at 20–25 °C to a concentration of 25–35 % w/w. An automatic pH-stat equipped with a glass electrode and a dosing pump for 30 % w/w sodium hydroxide solution is connected to the reactor. The batch is cooled to 0–5 °C, and a fatty acid chloride, typically lauroyl chloride or a narrow-range cocoyl chloride fraction, is metered into the reactor through a dip tube. The addition rate is controlled to keep the pH within 8.5–9.0; at this pH the free amino group is reactive and the methyl ester remains largely intact. If the pH drifts below 7.0, the amino group converts to the unreactive ammonium form and the acylation stalls; if the pH rises above 10.0, methyl ester hydrolysis produces N-acyl-L-alanine directly, which can be intended but complicates downstream extraction and may require a subsequent acidification step. The pH-stat logic uses dead-band control with 0.1 pH hysteresis to avoid caustic overshoot, and the sodium hydroxide solution is precooled to 5 °C. Exothermic acylation is managed by jacket cooling with chilled brine at -10 to 0 °C. After fatty acid chloride addition, the batch is allowed to reach 10–15 °C and held until thin-layer chromatography or gas chromatography shows residual fatty acid chloride below the detection limit. The organic phase is separated, washed with water containing 2–3 % w/w sodium chloride to break emulsions, and dried over anhydrous sodium sulfate. The resulting N-acyl methyl ester is then saponified with 1.05–1.10 molar equivalents of sodium hydroxide in water or aqueous methanol to yield the sodium N-acyl-L-alaninate surfactant. The methyl ester retention step separates the acylation and saponification operations so that each can be controlled independently; this is particularly relevant when the acyl chain is longer than C12, where direct acylation in strongly alkaline water tends to produce gel phases. The final surfactant is evaluated for residual fatty acid content by acid value titration and for biodegradability according to OECD 301B. The process equipment is validated for cleanability by rinsing with methanol and quantifying chloride residues by ion chromatography. A common production-scale failure pattern is emulsion formation at the interface during scale-up when the organic-to-aqueous volume ratio drops below 0.8:1.0; correcting the solvent ratio and using baffled reactors with controlled agitator tip speed restores clean phase separation. Published data for the exact steady-state mass transfer coefficient in a multitonne vessel is limited, but the qualitative phase inversion behaviour is consistent with standard stirred-tank extraction correlations.

Reduction of the methyl ester hydrochloride to L-alaninol remains a workable route where the chiral amino alcohol is needed for oxazaborolidine catalyst synthesis or as a C-terminal alcohol building block. The salt is charged to an anhydrous tetrahydrofuran slurry and fed slowly to a stirred suspension of lithium aluminium hydride under a nitrogen or argon atmosphere. Because the hydrochloride proton consumes hydride equivalents, the charge of lithium aluminium hydride is calculated on the basis of both the ester reduction and the neutralization of one molar equivalent of hydrogen chloride; insufficient hydride charge leaves unreduced ester, while excessive charge enlarges the quench duty and the aluminium waste stream. The addition is run at 0–5 °C; after the addition the batch is warmed to 20–25 °C for completion. The reactor is fitted with a pressure-rated vent and a flame arrestor because hydrogen is evolved when the salt is neutralized. Equipment protection levels follow 1999/92/EC for explosive atmospheres. Quenching uses the sequential water, 15 % w/w sodium hydroxide, and water protocol to convert aluminium by-products into filterable solids. The tetrahydrofuran layer is separated by filtration over a pressure filter, and the solvent is removed by distillation at reduced pressure. The crude L-alaninol is then distilled under vacuum; the fraction is collected as a colourless oil and stored under nitrogen. Water content in the tetrahydrofuran is controlled below 0.1 % by Karl Fischer titration before charging, because moisture consumes hydride and lowers the effective reducing charge. This route is incompatible with large-scale glass equipment and is normally run in stainless steel or glass-lined vessels with spark-proof agitation. The recovered L-alaninol is used in the synthesis of chiral oxazaborolidines or in the preparation of enantiopure oxazolidinone auxiliaries, where the stereocentre is retained from L-alanine methyl ester hydrochloride. The main operational boundary is the violent reaction between lithium aluminium hydride and water; the quench water addition rate must be slow enough to avoid foaming and localized overheating. Batch records from production-scale runs commonly show yield drops when the tetrahydrofuran water content exceeds the specified limit or when the hydride suspension is not agitated adequately.

What Are the pH Limits When Boc Anhydride Is Charged to an Aqueous Slurry of the Hydrochloride?

N-tert-Butoxycarbonyl protection of L-alanine methyl ester hydrochloride is carried out to produce Boc-L-alanine methyl ester, a widely used intermediate for peptide coupling. The hydrochloride salt is dissolved in a mixture of water and dichloromethane at 20–25 °C. Sodium bicarbonate or 10 % w/w aqueous sodium carbonate is added to neutralise the hydrochloride and maintain the aqueous pH between 8.0 and 9.0. Di-tert-butyl dicarbonate is then fed as a dichloromethane solution. The reaction produces one mole of carbon dioxide and one mole of tert-butanol per mole of Boc anhydride; the vent line and alkaline scrubber must be sized for this volumetric gas evolution. The pH is held below 9.0 because the methyl ester undergoes base-catalyzed hydrolysis under more alkaline conditions, producing Boc-L-alanine acid that remains in the aqueous phase and is lost during workup. Above pH 10, this loss route can become the dominant side reaction in poorly mixed regions, particularly near the caustic addition point. Agitation is therefore designed to disperse the base before it contacts the ester phase; a pitched-blade turbine or retreated-curve impeller is used in glass-lined reactors. The reaction is monitored by thin-layer chromatography or gas chromatography for the disappearance of di-tert-butyl dicarbonate. The dichloromethane phase is separated, washed with water and 20 % w/w brine, and concentrated at a jacket temperature not exceeding 40 °C. The product is obtained as a pale oil. Enantiomeric purity is checked by chiral gas chromatography or supercritical fluid chromatography. Residual water is measured by Karl Fischer titration according to USP <921>. The process is not compatible with primary or secondary amines other than the substrate because residual bases can form carbamates or promote ester aminolysis. A batch-scale failure frequently traced to raw material variability is slow phase separation caused by excess sodium bicarbonate; controlling the carbonate charge to 1.2–1.5 molar equivalents relative to the hydrochloride and maintaining the dichloromethane-to-water volume ratio above 1.2:1.0 restores clean separation. This N-protection route provides the intermediate with the methyl ester retained for subsequent coupling or hydrolysis.

Synthesis of L-alanine N-carboxyanhydride from the methyl ester hydrochloride proceeds through initial saponification to L-alanine, followed by cyclisation with triphosgene in anhydrous tetrahydrofuran or ethyl acetate. The saponification step is performed by adding aqueous sodium hydroxide to the hydrochloride at 0–5 °C, then warming to 20 °C and distilling off the liberated methanol under reduced pressure. The resulting L-alanine solution is acidified to the isoelectric point, filtered, and dried. L-Alanine is then suspended in dry tetrahydrofuran and treated with triphosgene under a nitrogen atmosphere. The reaction releases hydrogen chloride and carbon dioxide; the reactor is coupled to an alkaline scrubber, and the reactor internals are selected for acid resistance. The reaction temperature is held at 40–50 °C until the suspension clears, after which the solvent is removed and the crude N-carboxyanhydride is recrystallised from anhydrous ethyl acetate or tetrahydrofuran-hexane. Water content in the solvent is controlled below 0.05 % by Karl Fischer titration because residual moisture initiates ring-opening polymerization and produces oligomeric contaminants. The purified L-alanine N-carboxyanhydride is used as a monomer in ring-opening polymerization to prepare poly-L-alanine segments for peptide-based biomaterials and controlled-release formulations. Handling triphosgene requires a gas scrubber and strict personnel exposure controls under local chemical safety regulations; the monomer is also sensitive to atmospheric moisture and is stored under nitrogen. Published quantitative data for this specific configuration is limited, but the route is employed when isolation of zwitterionic L-alanine prior to cyclisation is preferred over direct NCA formation from the hydrochloride.